SCHEMBL7701970

SCHEMBL7701970

CC(NOCc1ccccc1)C(=O)OP(=O)(O)O

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
MMP2 P08253 1/20 0.45
CA9 Q16790 1/20 0.45
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
ELANE P08246 1/20 0.42
HSD17B10 Q99714 1/20 0.41
MME P08473 1/20 0.41
ECE1 P42892 1/20 0.41
CETP P11597 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5142558 1.00 NPC1 (0.45) NPC1RAB9ACA1CA2MMP2
SCHEMBL7701967 0.90 NPC1 (0.46) NPC1RAB9ACA1CA2MMP2
SCHEMBL4282703 0.89 CA1 (0.46) NPC1RAB9ACA1CA2MMP2
SCHEMBL7214212 0.89 NPC1 (0.47) NPC1RAB9ACA1CA2MMP2
SCHEMBL4265208 0.89 NPC1 (0.47) NPC1RAB9ACA1CA2MMP2
SCHEMBL4282571 0.89 CA1 (0.46) NPC1RAB9ACA1CA2MMP2
SCHEMBL27536452 0.89 CA1 (0.46) NPC1RAB9ACA1CA2MMP2
SCHEMBL1287355 0.87 CA1 (0.47) NPC1RAB9ACA1CA2MMP2
SCHEMBL5144950 0.87 TSHR (0.42) NPC1RAB9ACA1CA2MMP2
SCHEMBL7207832 0.86 MEN1 (0.41) CA1CA2MMP2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117486959-A Synthesis of phosphate derivatives 努卡那有限公司 2024-02-02 CN disclosed
CN-110753697-B Synthesis of Phosphate Derivatives 努卡那有限公司 2023-10-13 CN disclosed
CN-110753697-A Synthesis of phosphate derivatives 努卡那有限公司 2020-02-04 CN disclosed
US-6350736-B1 phenyl methoxyalaninyl phosphate derivatives of 2',3'-didehydro-2',3'-dideoxythymidine with an electron-withdrawing moiety, such as p-bromo, for enhanced hydrolysis, have increased potency without high cytotoxic activity; inhibitors of HIV reverse transcriptase; thymidine-kinase (TK)-deficient cells PARKER HUGHES INSTITUTE 2002-02-26 US disclosed